National Council for Prescription Drug Programs indexing - billing unit

Manufacturer: National Council for Prescription Drug Programs
Effective date: 2012-07-24
Label type: Indexing - Billing Unit
Version: 1
Source: full-release
Hydrated at: 2026-06-05 01:54:32

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0456-0600-10	EA - Each	0456-0600	60b6dd6d-7ea2-467e-bc52-657d9a5706b5	1	2012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
0456-0600	0456-0600-10

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N200327-001	TEFLARO	CEFTAROLINE FOSAMIL	400MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29
N200327-002	TEFLARO	CEFTAROLINE FOSAMIL	600MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
N200327-001	AP
N200327-002	AP

Orange Book patents#

Current patent rows page 1 of 1 · 4 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N200327-001	9629861	2030-09-21		Drug product	2017-05-17
N200327-001	8247400	2031-02-10	U-282	Drug product
N200327-002	9629861	2030-09-21		Drug product	2017-05-17
N200327-002	8247400	2031-02-10	U-282	Drug product

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS	AP	RLD, RS	2010-10-29	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N200327-001	TEFLARO	400MG/VIAL	POWDER / INTRAVENOUS		RLD	2010-10-29	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N200327-002	TEFLARO	600MG/VIAL	POWDER / INTRAVENOUS		RLD, RS	2010-10-29	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N200327-001	AP	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N200327-002	AP	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N200327-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N200327-002	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N200327-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N200327-002	AP	1	`011fe1cb6892…`
2022-04-04 05:41 UTC	2022-04	N200327-001	AP	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N200327-002	AP	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	N200327-001	AP	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N200327-002	AP	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N200327-001	AP	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N200327-002	AP	1	`782e0a99824c…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N200327-001	AP	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N200327-002	AP	1	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 7 · 244 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N200327-001	8247400	2031-02-10	U-282	Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N200327-002	8247400	2031-02-10	U-282	Drug product		`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N200327-001	8247400	2031-02-10	U-282	Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N200327-002	8247400	2031-02-10	U-282	Drug product		`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N200327-001	8247400	2031-02-10	U-282	Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N200327-002	8247400	2031-02-10	U-282	Drug product		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N200327-001	8247400	2031-02-10	U-282	Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N200327-002	8247400	2031-02-10	U-282	Drug product		`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N200327-001	8247400	2031-02-10	U-282	Drug product		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N200327-002	8247400	2031-02-10	U-282	Drug product		`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N200327-001	8247400	2031-02-10	U-282	Drug product		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N200327-002	8247400	2031-02-10	U-282	Drug product		`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N200327-001	8247400	2031-02-10	U-282	Drug product		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N200327-002	8247400	2031-02-10	U-282	Drug product		`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N200327-001	8247400	2031-02-10	U-282	Drug product		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N200327-002	8247400	2031-02-10	U-282	Drug product		`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N200327-001	8247400	2031-02-10	U-282	Drug product		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N200327-002	8247400	2031-02-10	U-282	Drug product		`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N200327-001	9629861	2030-09-21		Drug product	2017-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N200327-001	8247400	2031-02-10	U-282	Drug product		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N200327-002	9629861	2030-09-21		Drug product	2017-05-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N200327-002	8247400	2031-02-10	U-282	Drug product		`5bbf6a4d5a75…`

Observed Orange Book exclusivity history#

Exclusivity history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N200327-001	NPP	2022-09-13	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N200327-002	NPP	2022-09-13	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N200327-001	NPP	2022-09-13	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N200327-002	NPP	2022-09-13	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N200327-001	NPP	2022-09-13	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N200327-002	NPP	2022-09-13	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N200327-001	NPP	2019-05-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N200327-001	NPP	2019-05-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N200327-002	NPP	2019-05-27	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N200327-002	NPP	2019-05-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N200327-001	NPP	2022-09-13	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	N200327-002	NPP	2022-09-13	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N200327-001	NPP	2022-09-13	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	N200327-002	NPP	2022-09-13	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N200327-001	NPP	2022-09-13	`87673890dc5c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N200327-002	NPP	2022-09-13	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N200327-001	NPP	2022-09-13	`5aa47cf7b7d7…`
2021-03-12 10:30 UTC	2021-03	N200327-002	NPP	2022-09-13	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N200327-001	NPP	2022-09-13	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N200327-002	NPP	2022-09-13	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N200327-001	NPP	2022-09-13	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N200327-002	NPP	2022-09-13	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N200327-001	NPP	2019-05-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N200327-001	NPP	2019-05-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N200327-002	NPP	2019-05-27	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N200327-002	NPP	2019-05-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N200327-001	NPP	2019-05-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N200327-001	NPP	2019-05-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N200327-002	NPP	2019-05-27	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N200327-002	NPP	2019-05-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N200327-001	NPP	2019-05-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N200327-001	NPP	2019-05-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N200327-002	NPP	2019-05-27	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N200327-002	NPP	2019-05-27	`ea99ee380514…`
2023-01-26 05:58 UTC	2023-01	N200327-001	NPP	2022-09-13	`3bdfa0b2c4d7…`
2023-01-26 05:58 UTC	2023-01	N200327-002	NPP	2022-09-13	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N200327-001	NPP	2022-09-13	`3a93d1ddd44b…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N200327-002	NPP	2022-09-13	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N200327-001	NPP	2022-09-13	`f41ea6bd6efb…`
2022-10-28 04:53 UTC	2022-10	N200327-002	NPP	2022-09-13	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Teflaro	CEFTAROLINE FOSAMIL	Allergan, Inc.	3ecde48b-75a2-4beb-9999-369f3f61bb8a	2024-11-20	Warnings, Adverse reactions	Exact identifier ndc (package): 0456-0600-10 ndc11 (package): 00456060010

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.